Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Michelle Eagle.

Newcastle AuthorsTitleYearFull text
Meredith James
Dr Michelle Eagle
Robert Muni Lofra
Dr ursula Moore
Dr Michela Guglieri
et al.
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale2022
Dr Michela Guglieri
Emerita Professor Katherine Bushby
Professor Elaine McColl
Chris Speed
Jennifer Wilkinson
et al.
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial2022
Dr Anna Mayhew
Dionne Moat
Dr Michelle Eagle
Meredith James
Robert Muni Lofra
et al.
Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy2022
Meredith James
Dr Michelle Eagle
Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic2021
Dr Anna Mayhew
Roberto Fernandez-Torron
Dr Michelle Eagle
Karen Bettinson
Professor Andrew Blamire
et al.
Assessment of disease progression in dysferlinopathy – a 1 year cohort study2019
Dr Alex Murphy
Meredith James
Dr Anna Mayhew
Dr Michelle Eagle
Dr Kieren Hollingsworth
et al.
Natural history of limb girdle musclar dystrophy R9 over 6 years: searching for trial endpoints2019
Rebecca Crow
Professor Elaine McColl
Dr Jennifer Wilkinson
Dr Michelle Eagle
Professor Hanns Lochmuller
et al.
A checklist for clinical trials in rare disease: obstacles and anticipatory actions—lessons learned from the FOR-DMD trial2018
Professor Jordi Diaz Manera
Roberto Fernandez-Torron
Meredith James
Dr Anna Mayhew
Dr Fiona Smith
et al.
Muscle MRI in dysferlinopathy patients: Pattern recognition and implications for clinical trials2018
Dr Ursula Moore
Roberto Fernandez-Torron
Meredith James
Dr Anna Mayhew
Dr Michelle Eagle
et al.
Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study2018
Dr Michelle Eagle
A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy2017
Dr Michelle Eagle
Aquatic therapy for children with duchenne muscular dystrophy: A pilot feasibility randomised controlled trial and mixed-methods process evaluation2017
Dr Michela Guglieri
Emerita Professor Katherine Bushby
Professor Elaine McColl
Dr Jennifer Wilkinson
Dr Michelle Eagle
et al.
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy2017
Dr Ursula Moore
Meredith James
Dr Anna Mayhew
Dr Fiona Smith
Dr Lizzie Harris
et al.
Clinical outcome study for dysferlinopathy: One-year follow-up2016
Dr Anna Mayhew
Dr Michelle Eagle
Dr Michela Guglieri
Professor Volker Straub
Professor Hanns Lochmuller
et al.
Corrigendum to Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT) (vol 25, pg 937, 2015)2016
Dr Michelle Eagle
Dr Anna Mayhew
Dr Michela Guglieri
Professor Volker Straub
Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials2016
David Rawlings
Dr Claire Wood
Professor Timothy Cheetham
Dr Cecilia Jimenez Moreno
Dr Anna Mayhew
et al.
Prophylactic oral bisphosphonate therapy in duchenne muscular dystrophy2016
Dr Lizzie Harris
Dr Catherine Bladen
Dr Anna Mayhew
Meredith James
Karen Bettinson
et al.
The Clinical Outcome Study for dysferlinopathy: An international multicenter study2016
Dr Henriette van Ruiten
Dr Chiara Marini Bettolo
Professor Timothy Cheetham
Dr Michelle Eagle
Professor Hanns Lochmuller
et al.
Why are some patients with Duchenne muscular dystrophy dying young: An analysis of causes of death in North East England2016
Rebecca Crow
Dr Michela Guglieri
Professor Elaine McColl
Dr Jennifer Wilkinson
Dr Michelle Eagle
et al.
Anticipating and overcoming obstacles in setting up NIH funded academic led, international clinical trials in rare disease - learning from for DMD2015
Dr Michelle Eagle
Baseline characteristics of the CINRG infantile facioscapulohumeral muscular dystrophy cohort2015
Professor Volker Straub
Olav Veldhuizen
Dr Marta Bertoli
Dr Michelle Eagle
Consortium for Products Across Europe in Duchenne Muscular Dystrophy (SCOPE-DMD)2015
Dr Anna Mayhew
Dr Michelle Eagle
Dr Michela Guglieri
Professor Volker Straub
Professor Hanns Lochmuller
et al.
Development and Psychometric Analysis of the Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool (DMDSAT)2015
Dr Michelle Eagle
Does an inability to achieve plantargrade at the ankle joint have an impact on the outcome measures of the six minute walking test and North Star ambulatory assessment; and is this further compounded by illio-tibial band tightness?2015
Dr Cecilia Jimenez Moreno
Dr Sira Moreno
Dr Michelle Eagle
Dr Anna Mayhew
Meredith James
et al.
Impact of three decades of improvement in standards of care for Duchenne muscular dystrophy2015
Dr Michelle Eagle
Dr Michela Guglieri
Professor Volker Straub
Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials2015
Dr Henriette van Ruiten
Dr Michela Guglieri
Dr Michelle Eagle
Professor Volker Straub
Professor Hanns Lochmuller
et al.
Overview of morbidity, mortality and survival in Duchenne muscular dystrophy in the North East of England2015
Dr Anna Mayhew
Meredith James
Dr Michelle Eagle
Dr Catherine Bladen
Karen Bettinson
et al.
Preparation of a disease specific functional measure suitable for trials in dysferlinopathy2015
Dr Michela Guglieri
Professor Elaine McColl
Dr Jennifer Wilkinson
Dr Michelle Eagle
Emerita Professor Katherine Bushby
et al.
Recruitment in the FOR-DMD study - double-blind randomized trial to optimize steroid regime in Duchenne Muscular Dystrophy (DMD)2015
Emerita Professor Katherine Bushby
Dr Michelle Eagle
Ataluren treatment of patients with nonsense mutation dystrophinopathy2014
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients2014
Dr Lizzie Harris
Karen Bettinson
Meredith James
Dr Anna Mayhew
Dr Michelle Eagle
et al.
International Clinical Outcome Study in Dysferlinopathy (COS): Results of screening questionnaires in UK patients2014
Dr Michelle Eagle
Emerita Professor Katherine Bushby
One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development2014
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Anna Mayhew
Emerita Professor Katherine Bushby
et al.
Quantitative Magnetic Resonance Imaging in Limb-Girdle Muscular Dystrophy 2I: A Multinational Cross-Sectional Study2014
Professor Volker Straub
Dr Michelle Eagle
Dr Michela Guglieri
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study2014
Dr Amina Chaouch
Dr Fiona Norwood
Professor Rita Horvath
Professor Patrick Chinnery
Dr Tuomo Polvikoski
et al.
Two recurrent mutations are associated with GNE myopathy in the North of Britain2014
Dr Anna Sarkozy
Dr Debbie Hicks
Dr Steven Laval
Dr Rita Barresi
Dr Lizzie Harris
et al.
ANO5 Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene Mutation2013
Dr Michelle Eagle
Dr Anna Mayhew
Karen Bettinson
Meredith James
Dr Brigitta von Rekowski
et al.
Clinical outcome measures for dysferlinopathy: An exploration of reliability and suitability of novel functional rating scales2013
Dr Anna Mayhew
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy2013
Dr Kieren Hollingsworth
Dr Penelope Garrood
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
et al.
Magnetic resonance imaging in duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months2013
Dr Anna Mayhew
Dr Michelle Eagle
Meredith James
Emerita Professor Katherine Bushby
Performance of Upper Limb Scale for use in Duchenne muscular dystrophy - An iterative process to establish its suitability for clinical trials2013
Matias Wagner
Dr Amina Chaouch
Dr Juliane Mueller
Dr Tuomo Polvikoski
Dr Tracey Willis
et al.
Presymptomatic late-onset Pompe disease identified by the dried blood spot test2013
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Anna Mayhew
Emerita Professor Katherine Bushby
et al.
Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study2013
Dr Liesbeth De Waele
Dr Michelle Eagle
Dr Richard Charlton
Dr Langping He
Dr Emma Watson
et al.
Recessive desmin-null muscular dystrophy with central nuclei and mitochondrial abnormalities2013
Meredith James
Dr Michelle Eagle
Dr Anna Mayhew
Clinical Evaluator training for the GSK DEMAND programme2012
Dr Michelle Eagle
Dr Anna Mayhew
Dr Eugen-Matthias Strehle
Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy2012
Dr Michelle Eagle
Dr Anna Mayhew
Development of an upper limb functional scale in dystrophinopathies2012
Dr Anna Mayhew
Dr Michelle Eagle
Exploratory Rasch analysis of the EK2 scale used in a population of Duchenne muscular dystrophy (DMD)2012
Dr Anna Sarkozy
Dr Tuomo Polvikoski
Dr Michelle Eagle
Professor Hanns Lochmuller
Emerita Professor Katherine Bushby
et al.
Progressive core myopathy with dilated cardiomyopathy, respiratory failure and severe scoliosis caused by a novel mutation in the MYH7 gene2012
Dr Anna Mayhew
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Trial readiness: Clinical interpretability of change scores of the North Star Ambulatory Assessment in Duchenne muscular dystropy2012
Dr Debbie Hicks
Dr Anna Sarkozy
Dr Nuria Muelas Gomez
Dr Gavin Hudson
Professor Patrick Chinnery
et al.
A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy2011
Dr Debbie Hicks
Dr Anna Sarkozy
Dr Nuria Muelas Gomez
Dr Gavin Hudson
Professor Patrick Chinnery
et al.
A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy2011
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Anna Mayhew
Emerita Professor Katherine Bushby
et al.
Assessing muscle pathology by MRI in LGMD2I2011
Dr Michelle Eagle
Assessing upper limb function in nonambulant SMA patients: Development of a new module2011
Dr Michela Guglieri
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Body mass index (BMI) and growth in Duchenne Muscular Dystrophy (DMD)2011
Dr Anna Mayhew
Dr Michelle Eagle
Dr Tracey Willis
Professor Volker Straub
Exploratory Rasch analysis of adapted North Star ambulatory assessment in LGMD 2I2011
Dr Anna Mayhew
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
Dr Anna Sarkozy
et al.
Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy2011
Dr Anna Sarkozy
Dr Michelle Eagle
Dr Richard Charlton
Dr Rita Barresi
Professor Hanns Lochmuller
et al.
Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene2011
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Anna Mayhew
Emerita Professor Katherine Bushby
et al.
Quantitative MRI in LGMD2I; a longitudinal study2011
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Hanns Lochmuller
et al.
Assessing muscle pathology by MRI in LGMD2I2010
Emerita Professor Katherine Bushby
Dr Michelle Eagle
Consensus Statement on Standard of Care for Congenital Muscular Dystrophies2010
Dr Michela Guglieri
Professor Elaine McColl
Dr Michelle Eagle
Dr Karen Rafferty
Emerita Professor Katherine Bushby
et al.
FOR-DMD: double-blind randomized trial to optimize steroid regime in Duchenne Muscular Dystrophy (DMD)2010
Dr Michelle Eagle
Dr Anna Mayhew
Dr Tracey Willis
Professor Hanns Lochmuller
Emerita Professor Katherine Bushby
et al.
Functional outcome measures in limb girdle muscular dystrophy 21: Correlations with MRI2010
Dr Tracey Willis
Dr Kieren Hollingsworth
Professor Andrew Blamire
Dr Michelle Eagle
Emerita Professor Katherine Bushby
et al.
MRI in LGMD21: a qualitative and quantitative analysis using the 3 point Dixon technique2010
Dr Lars Klinge
Dr Michelle Eagle
Dr John Hudson
Dr Anna Sarkozy
Dr Richard Charlton
et al.
New aspects on patients affected by dysferlin deficient muscular dystrophy2010
Emerita Professor Katherine Bushby
Dr Michelle Eagle
The Respiratory Management of Patients With Duchenne Muscular Dystrophy: A DMD Care Considerations Working Group Specialty Article2010
Dr Michelle Eagle
Assessment of StepWatch (TM) activity monitoring in phase 2b study of ataluren (PTC124 (TM)) in nmDMD/BMD2009
Dr Penelope Garrood
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Benjamin Aribisala
Dr Daniel Birchall
et al.
MR Imaging in Duchenne Muscular Dystrophy: Quantification of T-1-Weighted Signal, Contrast Uptake, and the Effects of Exercise2009
Professor Timothy Cheetham
Professor Simon Pearce
David Rawlings
Dr Michelle Eagle
Dr Michela Guglieri
et al.
Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne muscular dystrophy2009
Dr Fiona Norwood
Professor Patrick Chinnery
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
et al.
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population2009
Dr Michelle Eagle
Reliability of the North Star Ambulatory Assessment in a multicentric setting2009
Dr Michelle Eagle
Lisa Atkinson
T.P.3.05: Reproducibility and correlation of pretreatment outcome measures in phase 2b study of ataluren (PTC124 (TM)) in nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD)2009
Emerita Professor Katherine Bushby
Dr Michelle Eagle
Dr Eugen-Matthias Strehle
Professor Volker Straub
13th International WMS Congress, 29th September - 2nd October 2008, Newcastle Gateshead, UK2008
Emerita Professor Katherine Bushby
Dr Michelle Eagle
Professor Volker Straub
A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy2008
Dr Richard Charlton
Dr Rita Barresi
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
et al.
Caveolinopathy - New mutations and additional symptoms2008
Dr Michela Guglieri
Geoff Bell
Dr John Bourke
Dr Michelle Eagle
Professor Patrick Chinnery
et al.
Clinical follow up in a large cohort of patients affected by Myotonic Dystrophy type2008
Dr Michela Guglieri
Geoff Bell
Dr John Bourke
Dr Michelle Eagle
Professor Patrick Chinnery
et al.
D.P.2.02: Development of a nurse led multidisciplinary clinic for myotonic dystrophy type 12008
Dr Michela Guglieri
Geoff Bell
Dr John Bourke
Dr Michelle Eagle
Professor Patrick Chinnery
et al.
D.P.2.03: Clinical follow up in a large cohort of patients affected by myotonic dystrophy type 12008
Dr Rita Barresi
Dr Richard Charlton
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
et al.
D.P.3.09: Caveolinopathy - New mutations and additional symptoms2008
Dr Michela Guglieri
Dr Michelle Eagle
Dr John Bourke
Professor Volker Straub
Emerita Professor Katherine Bushby
et al.
Delayed development and learning difficulties as a predominant symptom in female carriers of Duchenne and Becker muscular dystrophy2008
Dr Michela Guglieri
Geoff Bell
Dr John Bourke
Dr Michelle Eagle
Professor Patrick Chinnery
et al.
Development of a nurse led multidisciplinary clinic for myotonic dystrophy type 12008
Dr Michelle Eagle
Egen classification revisited in SMA2008
Dr Michelle Eagle
Professor Elaine McColl
Geoff Bell
Emerita Professor Katherine Bushby
Equipoise concerning corticosteroid use in boys with Duchenne muscular dystrophy: persistent wide variations in practice2008
Dr Michela Guglieri
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
Is assessment of respiratory function a good outcome measure for SMA II and III?2008
Dr Penelope Garrood
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy2008
Dr Richard Charlton
Dr Rita Barresi
Dr Louise VB Anderson
Dr Michelle Eagle
Dr Mauro Santibanez Koref
et al.
Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A2007
Dr Michelle Eagle
Dr Michela Guglieri
Professor Volker Straub
Emerita Professor Katherine Bushby
Long term steroid use in non-ambulatory patients with Duchenne muscular dystrophy2007
Dr Michelle Eagle
Dr John Bourke
Dr Robert Bullock
Professor Volker Straub
Emerita Professor Katherine Bushby
et al.
Managing Duchenne muscular dystrophy - The additive effect of spinal surgery and home nocturnal ventilation in improving survival2007
Dr Penelope Garrood
Dr Kieren Hollingsworth
Professor Peter Thelwall
Dr Daniel Birchall
Dr Michelle Eagle
et al.
MRI in Duchenne muscular dystrophy: Quantification of fat infiltration and gadolinium uptake using whole-muscle regions of interest2007
Dr Penelope Garrood
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
Myoglobinuria in steroid-treated Duchenne muscular dystrophy2007
Dr Michelle Eagle
Dr Michela Guglieri
Professor Volker Straub
Emerita Professor Katherine Bushby
Steroids in Duchenne muscular dystrophy (DMD): Natural history and clinical evaluation using the North Star Ambulatory Assessment (NSAA)2007
Dr Michelle Eagle
[abstract] The North Star Ambulatory Assessment2006
Dr Inderbir Gill
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Dr Robert Bullock
Correction of neuromuscular scoliosis in patients with preexisting respiratory failure2006
Dr Anna Sarkozy
Dr Richard Charlton
Dr Michelle Eagle
Professor Patrick Chinnery
Professor Volker Straub
et al.
Phenotypic variability associated with desmin gene mutations2006
Dr Lars Klinge
Dr Michelle Eagle
Professor Volker Straub
Emerita Professor Katherine Bushby
Severe phenotype in infantile facioscapulohumeral muscular dystrophy2006
Dr Anne Lampe
Dr Michelle Eagle
Dr Mark Buddles
Professor Volker Straub
Emerita Professor Katherine Bushby
et al.
Bethlem myopathy, autosomal dominant and X-linked Emery Dreifuss muscular dystrophy - comparison of contractural phenotypes2005
Dr Michelle Eagle
David Rawlings
Professor Volker Straub
Emerita Professor Katherine Bushby
Bone density in patients with Duchenne muscular dystrophy (DMD)2005
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
Limb girdle muscular dystrophies - Dominant forms; Poster presentations2005
Dr Michelle Eagle
Professor Volker Straub
Emerita Professor Katherine Bushby
The impact of corticosteroids on forced vital capacity in Duchenne muscular dystrophy2005
Emerita Professor Katherine Bushby
Dr John Bourke
Dr Robert Bullock
Dr Michelle Eagle
Mark Gibson
et al.
The multidisciplinary management of Duchenne muscular dystrophy2005
Dr John Bourke
Dr Michelle Eagle
Professor Volker Straub
Emerita Professor Katherine Bushby
Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I2004
Dr Michelle Eagle
Professor Volker Straub
Emerita Professor Katherine Bushby
Experience of applying the UK consensus on the use of corticosteroids in DMD2004
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Report of a Muscular Dystrophy Campaign funded workshop to review the prevalence of osteoporosis in DMD and its treatment and prevention2004
Dr Michelle Eagle
Dr Robert Bullock
Emerita Professor Katherine Bushby
By simple non-invasive monitoring, the need for ventilation in Duchenne muscular dystrophy can be predicted2003
Dr Michelle Eagle
Dr John Bourke
Emerita Professor Katherine Bushby
Experience of spinal surgery and ventilation in 91 patients with Duchenne muscular dystrophy born between 1970 and 19882003
Dr Lynsey Cree
Dr John Bourke
Dr Michelle Eagle
Dr Louise VB Anderson
Dr Daniel Birchall
et al.
The phenotype of limb-girdle muscular dystrophy type 2I2003
Dr John Bourke
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Unusual phenotype in a case of laminopathy with childhood onset, short stature, mid-face hypoplasia and early respiratory failure2003
Dr Michelle Eagle
Exercise in neuromuscular diseases - an expert workshop report2002
Dr Michelle Eagle
Report on the Muscular Dystrophy Campaign workshop: Exercise in neuromuscular diseases Newcastle, January 20022002
Dr Michelle Eagle
Dr John Bourke
Dr Robert Bullock
Dr Lynsey Cree
Dr Mark Buddles
et al.
Respiratory and cardiac involvement are a primary part of limb-girdle muscular dystrophy 2I2002
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Facioscapulohumeral muscular dystrophy: gait analysis and effectiveness of ankle foot orthoses (AFOs)2001
Dr Michelle Eagle
Dr Robert Bullock
Emerita Professor Katherine Bushby
Multicore myopathy: Respiratory failure and paraspinal muscle contractures are important complications2000